Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
RENACER study: Assessment of 12-month efficacy and safety of 168 certolizumab PEGol rheumatoid arthritis-treated patients from a Spanish multicenter national database.
Torrente-Segarra V, Urruticoechea Arana A, Sánchez-Andrade Fernández A, Tovar Beltrán JV, Muñoz Jiménez A, Martínez-Cristóbal A, González Ferrández JA, Fernández Prada M, Vázquez Fuentes N, Corominas H, García-Díaz S, Acosta Pereira A, Ruiz Martín JM, Lamua Riazuelo JR, Expósito Moliner R, Ruiz Vilchez D, Veiga Cabello R, Fernández JC, Noguera Pons JR, Garrido Puñal NP, Giralt Celiméndiz P, Cortés Verdú R, Aragón Díez A, Tomás Roura C, Moll Turudi C, Taverner Torrent D, Rivas Santirso FJ, Lerma Garrido JJ, García Portales R, Ordoñez Palau S, Paredes González-Albo S, Gracia Pérez A, Conesa Mateos A, Calvo Alén J, Graña Gil J, Navarro Alonso MP, Martínez Blasco MJ; (RENACER StudyGroup). Torrente-Segarra V, et al. Among authors: ordonez palau s. Mod Rheumatol. 2016 May;26(3):336-341. doi: 10.3109/14397595.2015.1101200. Epub 2015 Nov 7. Mod Rheumatol. 2016. PMID: 26418571
Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients.
López-Maraver M, Serrano-Combarro A, Atienza-Mateo B, Del Val N, Casafont-Solé I, Melero-Gonzalez RB, Pérez-Linaza A, Calvo Gutiérrez J, Mena-Vázquez N, Vegas-Revenga N, Domínguez-Casas L, Loarce Martos J, Peralta Ginés CA, Diez Morrondo C, Pérez Albaladejo L, López Sánchez R, Manzano Canabal MG, Brandy-García AM, López Viejo P, Bonilla G, Maiz-Alonso O, Carrasco-Cubero C, Garijo Bufort M, Moreno M, Urruticoechea-Arana A, Ordóñez-Palau S, González-Montagut C, Giner Serret E, De Dios Jiménez De Aberasturi JR, Lozano Morillo F, Vázquez Rodríguez T, Carreira PE, Blanco Madrigal JM, Miguel Ibáñez B, Rodríguez López M, Fernández-Díaz C, Loricera J, Ferraz-Amaro I, Ferrer-Pargada D, Castañeda S, Blanco R; Spanish Collaborative Group of Abatacept in Interstitial Lung Disease Associated with Rheumatoid Arthritis. López-Maraver M, et al. Among authors: ordonez palau s. Semin Arthritis Rheum. 2024 Oct;68:152517. doi: 10.1016/j.semarthrit.2024.152517. Epub 2024 Jul 18. Semin Arthritis Rheum. 2024. PMID: 39067148
Abatacept in interstitial lung disease associated with rheumatoid arthritis: national multicenter study of 263 patients.
Fernández-Díaz C, Castañeda S, Melero-González RB, Ortiz-Sanjuán F, Juan-Mas A, Carrasco-Cubero C, Casafont-Solé I, Olivé A, Rodríguez-Muguruza S, Almodóvar-González R, Castellanos-Moreira R, Rodríguez-García SC, Aguilera-Cros C, Villa I, Ordóñez-Palau S, Raya-Alvarez E, Morales-Garrido P, Ojeda-García C, Moreno-Ramos MJ, Bonilla Hernán MG, Hernández Rodríguez I, López-Corbeto M, Andreu JL, Jiménez de Aberásturi JRD, Ruibal-Escribano A, Expósito-Molinero R, Pérez-Sandoval T, López-Robles AM, Carreira-Delgado P, Mena-Vázquez N, Urruticoechea-Arana A, Peralta-Ginés C, Arboleya-Rodríguez L, Narváez García FJ, Palma-Sánchez D, Cervantes Pérez EC, Maiz-Alonso O, Alvarez-Rivas MN, Fernández-Melón J, Vela Casasempere P, Cabezas-Rodríguez I, Castellvi-Barranco I, González-Montagut C, Blanco-Madrigal J, Del Val-Del Amo N, Fito MC, Rodríguez-Gómez M, Salgado-Pérez E, García-Magallón B, Hidalgo-Calleja C, López-Sánchez R, Fernández-Aguado S, Fernández-López JC, Castro-Oreiro S, Serrano-García I, García-Valle A, Romero-Yuste S, Expósito-Pérez L, Pérez-Albadalejo L, García-Aparicio A, Quillis-Marti N, Bernal-Vidal JA, Loricera-García J, Hernández JL, González-Gay MA, Blanco R. Fernández-Díaz C, et al. Among authors: ordonez palau s. Rheumatology (Oxford). 2020 Dec 1;59(12):3906-3916. doi: 10.1093/rheumatology/keaa621. Rheumatology (Oxford). 2020. PMID: 33068439
[Analysis of differences between indication and prescription of gastroprotection in patients with risk factors treated with nonsteroidal anti-inflammatory agents: the GAP study].
Lanas A, Muñoz M, Caballero Correa M, Martínez Jiménez P; investigadores del estudio GAP. Lanas A, et al. Gastroenterol Hepatol. 2010 Feb;33(2):80-91. doi: 10.1016/j.gastrohep.2009.09.009. Epub 2009 Nov 22. Gastroenterol Hepatol. 2010. PMID: 19931944 Clinical Trial. Spanish.